Correspondence
Free Access
Cytokine network during NASH and possible treatment selection
Zhiping Li M.D., Shiqi Yang M.D., Huizhi Lin M.D., Jiawen Huang M.D., Paul A. Watkins M.D.,
Ann B. Moser M.D.,
Claudio DeSimone M.D., Xiao-yu Song M.D., Anna Mae Diehl M.D.,
Paul A. Watkins M.D.
The Johns Hopkins University, Baltimore, MD
Kennedy Krieger Institute, Baltimore, MD
Search for more papers by this authorAnn B. Moser M.D.
The Johns Hopkins University, Baltimore, MD
Kennedy Krieger Institute, Baltimore, MD
Search for more papers by this authorAnna Mae Diehl M.D.
The Johns Hopkins University, Baltimore, MD
Search for more papers by this authorZhiping Li M.D., Shiqi Yang M.D., Huizhi Lin M.D., Jiawen Huang M.D., Paul A. Watkins M.D.,
Ann B. Moser M.D.,
Claudio DeSimone M.D., Xiao-yu Song M.D., Anna Mae Diehl M.D.,
Paul A. Watkins M.D.
The Johns Hopkins University, Baltimore, MD
Kennedy Krieger Institute, Baltimore, MD
Search for more papers by this authorAnn B. Moser M.D.
The Johns Hopkins University, Baltimore, MD
Kennedy Krieger Institute, Baltimore, MD
Search for more papers by this authorAnna Mae Diehl M.D.
The Johns Hopkins University, Baltimore, MD
Search for more papers by this authorFirst published: 31 January 2007
No abstract is available for this article.
References
- 1 Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, et al. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N Engl J Med 2001; 345: 1098–1104.
- 2 Helbling D, Breitbach TH, Krause M. Disseminated cytomegalovirus infection in Crohn's disease following anti-tumour necrosis factor therapy. Eur J Gastroenterol Hepatol 2002; 14: 1393–1395.
- 3 Kern PA, Saghizaheh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995; 95: 2111–2119.
- 4 Crespo J, Cayon A, Fernandez-Gil P, Hernandez-Guerra M, Mayorga M, Dominguez-Diez A, Fernandez-Escalante JC, et al. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 2001; 34: 1158–1163.
- 5 Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 2001; 48: 206–211.
- 6 Valenti L, Fracanzani AL, Dongiovanni P, Santorelli G, Branchi A, Taioli E, Fiorelli G, et al. Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. Gastroenterology 2002; 122: 274–280.
- 7 Loguercio C, DeSimone T, Federico A, Terracciano F, Tuccillo C, DiChicco M, Carteni M. Gut-liver axis: a new point of attack to treat chronic liver damage? Am J Gastroenterol 2002; 97: 2144–2146.
